1. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis
    Joseph George et al, 2019, Cell Death Dis CrossRef
  2. High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
    Hyuk Moon et al, 2019, IJMS CrossRef
  3. Phosphorylated Platelet-Derived Growth Factor Receptor-Positive Cells With Anti-apoptotic Properties Accumulate in the Synovium of Patients With Rheumatoid Arthritis
    Takashi Matsumura et al, 2019, Front. Immunol. CrossRef
  4. Rebaudioside A administration prevents experimental liver fibrosis: an in vivo and in vitro study of the mechanisms of action involved
    Sael Casas‐Grajales et al, 2019, J Appl Toxicol CrossRef
  5. Anti‐fibrotic mechanisms of angiotensin AT 2 ‐receptor stimulation
    Colin Sumners et al, 2019, Acta Physiol CrossRef
  6. siRNA- and miRNA-Based Therapeutics for Liver Fibrosis
    Zhen Zhao et al, 2019, Translational Research CrossRef
  7. null
    Le Thi Thanh Thuy et al, 2019 CrossRef
  8. Freeze-Dried Platelet-Rich Plasma Induces Osteoblast Proliferation via Platelet-Derived Growth Factor Receptor-Mediated Signal Transduction
    Hideyuki Kinoshita et al, 2019, Asian Spine J CrossRef
  9. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
    Pedro Melgar-Lesmes et al, 2019, Cells CrossRef
  10. Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells
    Junyan Yan et al, 2019, Toxicology Letters CrossRef
  11. Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis
    null Milito et al, 2019, Cells CrossRef
  12. Fibrotic Signaling Pathways of Skin Fibroblasts in Nephrogenic Systemic Fibrosis
    Saranya Ravi et al, 2019, Curr Geri Rep CrossRef
  13. The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis
    Qianglin Chen et al, 2019, Parasites Vectors CrossRef
  14. Platelet-Derived Growth Factor C in Alcoholics
    C Martín-González et al, 2020 CrossRef
  15. The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis
    Yuanqiang Lin et al, 2020, PLoS ONE CrossRef
  16. Cytokine profile in children with food allergy following liver transplantation
    Svanhildur Haflidadottir et al, 2020, Pediatr Transplant CrossRef
  17. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment
    Mariia Zadorozhna et al, 2020, Mol Biol Rep CrossRef
  18. Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism
    Caio Mateus Silva et al, 2020, Mol Cell Biochem CrossRef
  19. The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
    Manel B. Hammouda et al, 2020, Cells CrossRef
  20. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
    Natascha Roehlen et al, 2020, Cells CrossRef
  21. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
    Angeliki Katsarou et al, 2020, WJG CrossRef
  22. Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.
    Estefanía de Gregorio et al, 2020, Int J Mol Sci CrossRef
  23. The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix
    Michitaka Matsuda et al, 2020, Food and Chemical Toxicology CrossRef
  24. Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice
    Xiaohe Li et al, 2020, J Cell Mol Med CrossRef
  25. Astragaloside IV regulates NF‑κB‑mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF‑BB‑induced activation
    Zhiwei Chen et al, 2019, Exp Ther Med CrossRef
  26. Role of macrophages in experimental liver injury and repair in mice (Review)
    Xiaotian Dong et al, 2019, Exp Ther Med CrossRef
  27. Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models
    Joseph George et al, 2020, J Mol Med CrossRef
  28. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients
    Qun-Yan Yao et al, 2020, WJG CrossRef
  29. Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases
    Yajie Cai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  30. Uveal Melanoma Cells Elicit Retinal Pericyte Phenotypical and Biochemical Changes in an in Vitro Model of Coculture
    Carmelina Daniela Anfuso et al, 2020, IJMS CrossRef
  31. Key Players of Hepatic Fibrosis
    Reham M. Dawood et al, 2020, Journal of Interferon & Cytokine Research CrossRef
  32. Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
    Jiayao Yang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  33. Portal vein thrombosis due to essential thrombocythemia with limited cutaneous systemic sclerosis
    Kentaro Iwaki et al, 2020, Clin J Gastroenterol CrossRef
  34. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
    Kyoko Oura et al, 2020, IJMS CrossRef
  35. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis
    Giulia Chiabotto et al, 2020, Front. Cell Dev. Biol. CrossRef
  36. The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension
    Yuan Yuan et al, 2020, PLoS ONE CrossRef
  37. Tyrosine Kinases in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis and Potential Therapeutic Role of their Inhibition
    Fabian A. Mendoza et al, 2021, Translational Research CrossRef
  38. null
    Magisetty Obulesu, 2021 CrossRef
  39. Regulatory Effect of Mesenchymal Stromal Cells on the Development of Liver Fibrosis: Cellular and Molecular Mechanisms and Prospects for Clinical Application
    O. V. Payushina et al, 2021, Biol Bull Rev CrossRef
  40. Tectona grandis Leaf Extract Ameliorates Hepatic Fibrosis: Modulation of TGF- β /Smad Signaling Pathway and Upregulating MMP3/TIMP1 Ratio
    Somayya Tariq et al, 2021, Journal of Ethnopharmacology CrossRef
  41. Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia
    Jordi Ribera et al, 2021, ACS Nano CrossRef
  42. Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice
    Yi-Jen Liao et al, 2021, IJMS CrossRef
  43. Protective effects of paclitaxel on thioacetamide‐induced liver fibrosis in a rat model
    Maha H. Sharawy et al, 2021, J Biochem Mol Toxicol CrossRef
  44. null
    Halyna Kuznietsova et al, 2021 CrossRef
  45. Research progress of natural products interfering with cell signaling pathway in liver fibrosis
    Li-Jing Qin et al, 2021, Journal of Asian Natural Products Research CrossRef
  46. Advances in Hepatic Stellate Cells and Hepatic Fibrosis and Its Reverse
    万明 郑, 2021, ACM CrossRef
  47. Single Cell Gene Expression Analysis in a 3D Microtissue Liver Model Reveals Cell Type-Specific Responses to Pro-Fibrotic TGF-β1 Stimulation
    Catherine Jane Messner et al, 2021, IJMS CrossRef
  48. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
    Arshi Khanam et al, 2021, Cells CrossRef
  49. null
    Rinaldo Pellicano et al, 2021 CrossRef
  50. Antifibrotic Role of Nintedanib in Tracheal Stenosis After a Tracheal Wound
    Yuhua Fan et al, 2021, The Laryngoscope CrossRef
  51. Exogenous Plant gma-miR-159a, Identified by miRNA Library Functional Screening, Ameliorated Hepatic Stellate Cell Activation and Inflammation via Inhibiting GSK-3β-Mediated Pathways
    Wen-Ying Yu et al, 2021, JIR CrossRef
  52. High-throughput miRNA sequencing of the human placenta: expression throughout gestation
    Tania L Gonzalez et al, 2021, Epigenomics CrossRef
  53. Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
    Ruoyue Tan et al, 2021, Front. Oncol. CrossRef
  54. Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice
    Ho Yin Pekkle Lam et al, 2021, Journal of Microbiology, Immunology and Infection CrossRef
  55. Early infiltrating macrophage subtype correlates with late-stage phenotypic outcome in a mouse model of hepatorenal fibrocystic disease
    Kurt A. Zimmerman et al, 2021, Lab Invest CrossRef
  56. Expression of fibrosis‐related genes in liver allografts: Association with histology and long‐term outcome after pediatric liver transplantation
    Silja H. Voutilainen et al, 2021, Clin Transplant CrossRef
  57. Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
    Xin Huang et al, 2021, Front. Physiol. CrossRef
  58. Molecular-Genetic Basis of Gastrointestinal Stromal Tumor Personalized Therapy by Receptor Tyrosine Kinase Inhibitors (A Review)
    M. T. Kozinova et al, 2021, Pharm Chem J CrossRef
  59. Extracellular Matrix Remodeling in Chronic Liver Disease
    Cristina Ortiz et al, 2021, Curr. Tissue Microenviron. Rep. CrossRef
  60. Role of PDGF-A/B Ligands in Cardiac Repair After Myocardial Infarction
    Kunal Kalra et al, 2021, Front. Cell Dev. Biol. CrossRef
  61. Role of miRNA and lncRNAs in organ fibrosis and aging
    Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  62. Amnion-Derived Mesenchymal Stromal/Stem Cell Paracrine Signals Potentiate Human Liver Organoid Differentiation: Translational Implications for Liver Regeneration
    Antonio Lo Nigro et al, 2021, Front. Med. CrossRef
  63. Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
    Zhong-Yi Wang et al, 2021, Sci Rep CrossRef
  64. TDAG51 induces renal interstitial fibrosis through modulation of TGF-β receptor 1 in chronic kidney disease
    Rachel E. Carlisle et al, 2021, Cell Death Dis CrossRef
  65. MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period
    Tarana Arman et al, 2021, Toxicology CrossRef
  66. Targeting senescent cells improves functional recovery after spinal cord injury
    Diogo Paramos-de-Carvalho et al, 2021, Cell Reports CrossRef
  67. 1β-Hydroxyalantolactone from Inulae Flos alleviated the progression of pulmonary fibrosis via inhibiting JNK/FOXO1/NF-κB pathway
    Bing Yu et al, 2021, International Immunopharmacology CrossRef
  68. Surface engineering of 3D-printed scaffolds with minerals and a pro-angiogenic factor for vascularized bone regeneration
    Jinkyu Lee et al, 2021, Acta Biomaterialia CrossRef
  69. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
    Kaveh Baghaei et al, 2021, Drug Discovery Today CrossRef
  70. Hype or hope of hyaluronic acid for osteoarthritis: Integrated clinical evidence synthesis with multi-organ transcriptomics
    Kun Zhao et al, 2022, Journal of Orthopaedic Translation CrossRef
  71. Involvement of TREK1 channels in the proliferation of human hepatic stellate LX-2 cells
    Rubii Kondo et al, 2022, Journal of Pharmacological Sciences CrossRef
  72. Atheroprotective and hepatoprotective effects of trans-chalcone through modification of eNOS/AMPK/KLF-2 pathway and regulation of COX-2, Ang-II, and PDGF mRNA expression in NMRI mice fed HCD
    Mahsa Ale-Ebrahim et al, 2022, Mol Biol Rep CrossRef
  73. Regenerative Medicine Therapies for Prevention of Abdominal Adhesions: A Scoping Review
    Samuel P. Carmichael et al, 2022, Journal of Surgical Research CrossRef
  74. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Thanita Thongtan et al, 2022, Indian J Gastroenterol CrossRef
  75. LPS-TLR4/MD-2-TNF-α signaling mediates alcohol-induced liver fibrosis in rats.
    Wen-Ling Mou et al, 2022, J Toxicol Pathol CrossRef
  76. Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression
    Tingjie Wang et al, 2022, Hepatology CrossRef
  77. Chronic liver diseases: From development to novel pharmacological therapies
    Maria Teresa Borrello et al, 2022, British J Pharmacology CrossRef
  78. Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
    Yang Nan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  79. Liver secretin receptor predicts portoenterostomy outcomes and liver injury in biliary atresia
    Nimish Godbole et al, 2022, Sci Rep CrossRef
  80. Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism
    Dino Šisl et al, 2022, Biomedicines CrossRef
  81. Effects of inorganic nanoparticles on liver fibrosis: Optimizing a double-edged sword for therapeutics
    Jie Kai Tee et al, 2019, Biochemical Pharmacology CrossRef
  82. The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective
    Sofia Zanotti et al, 2022, Front. Med. CrossRef
  83. Targeting fibrosis, mechanisms and cilinical trials
    Manyu Zhao et al, 2022, Sig Transduct Target Ther CrossRef
  84. Physiologic and pathophysiologic roles of AKAP12
    Hui Li, 2022, Science Progress CrossRef
  85. Function and regulation of GPX4 in the development and progression of fibrotic disease
    Zhaobing Li et al, 2022, Journal Cellular Physiology CrossRef
  86. Integrated analysis using ToppMiR uncovers altered miRNA- mRNA regulatory networks in pediatric hepatocellular carcinoma-A pilot study.
    Senyo S Whyte et al, 2023, Cancer Rep (Hoboken) CrossRef
  87. Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis
    Anita M. van den Hoek et al, 2022, IJMS CrossRef
  88. Transcriptome changes in stages of non-alcoholic fatty liver disease
    Jihad Aljabban et al, 2022, WJH CrossRef
  89. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
    Wen-Qing Li et al, 2022, Front. Pharmacol. CrossRef
  90. Locally injected Mesenchymal Stem Cells optimize angiogenesis by regulating VEGF and CD31 expression in duodenal perforation
    Eko Setiawan et al, 2022, Annals of Medicine and Surgery CrossRef
  91. Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway
    Miki Inoue et al, 2022, Commun Biol CrossRef
  92. Melatonin promotes the proliferation of primordial germ cell-like cells derived from porcine skin-derived stem cells: A mechanistic analysis.
    Wen-Xiang Liu et al, 2022, J Pineal Res CrossRef
  93. Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
    Amanda N. Ruggieri et al, 2022 CrossRef
  94. Genetic Factors for Coronary Heart Disease and Their Mechanisms: A Meta-Analysis and Comprehensive Review of Common Variants from Genome-Wide Association Studies
    Khairul Anwar Zarkasi et al, 2022, Diagnostics CrossRef
  95. Anti-liver fibrosis activity of curcumin/chitosan-coated green silver nanoparticles
    Alya Elzoheiry et al, 2022, Sci Rep CrossRef
  96. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
    Melissa Yepmo et al, 2022, Front. Endocrinol. CrossRef
  97. Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis
    Mahmoud A. Younis et al, 2023, Journal of Controlled Release CrossRef
  98. Therapeutic interventions of acute and chronic liver disorders: A comprehensive review
    Fares EM Ali et al, 2023, World J Hepatol CrossRef
  99. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL‐6 pathway through miR‐124
    Helia Alavifard et al, 2023, Cell Biology International CrossRef
  100. Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis
    Archittapon Nokkeaw et al, 2023, Cells CrossRef
  101. null
    Ângela Cristina Malheiros Luzo et al, 2023 CrossRef
  102. Biochanin A in murine Schistosoma mansoni infection: effects on inflammation, oxidative stress and fibrosis
    A.A. Elhenawy et al, 2023, J. Helminthol. CrossRef
  103. Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells
    Rong Wang et al, 2023, International Journal of Biological Macromolecules CrossRef
  104. Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
    Leke Wiering et al, 2023, Cellular and Molecular Gastroenterology and Hepatology CrossRef
  105. Identification of circular dorsal ruffles as signal platforms for the AKT pathway in glomerular podocytes
    Rui Hua et al, 2023, Journal Cellular Physiology CrossRef
  106. Modern concepts on pathogenetic mechanisms of liver fibrosis
    N. A. Efremova et al, 2023, jour CrossRef
  107. Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression
    Evanthia Tourkochristou et al, 2023, IJMS CrossRef
  108. Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation
    Jinsheng Huang et al, 2023, Biomaterials CrossRef
  109. Oral Targeted Delivery of Imatinib by pH Responsive Copolymer Modulates Liver Fibrosis in the Mice Model
    Samaneh Siapoush et al, 2023, International Journal of Pharmaceutics CrossRef
  110. Towards a Unified Approach in Autoimmune Fibrotic Signalling Pathways
    Margherita Sisto et al, 2023, IJMS CrossRef
  111. Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
    Qiying Pei et al, 2023, IJMS CrossRef
  112. Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation
    Bakhovuddin Azamov et al, 2023, Molecules CrossRef
  113. Hepatic inflammatory responses in liver fibrosis
    Linda Hammerich et al, 2023, Nat Rev Gastroenterol Hepatol CrossRef
  114. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ
    Fangbin Liu et al, 2023, International Immunopharmacology CrossRef
  115. Integrated analysis of proteomics, epigenomics and metabolomics data revealed divergent pathway activation patterns in the recent versus chronic post-traumatic stress disorder
    Seid Muhie et al, 2023, Brain, Behavior, and Immunity CrossRef
  116. Yohimbine ameliorates liver inflammation and fibrosis by regulating oxidative stress and Wnt/β-catenin pathway
    Nidhi Sharma et al, 2023, Phytomedicine CrossRef
  117. Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
    Anja Hess et al, 2023, The EMBO Journal CrossRef
  118. Sex Drives Functional Changes in the Progression and Regression of Liver Fibrosis
    Katia Sayaf et al, 2023, IJMS CrossRef
  119. Pathological granuloma fibrosis induced by agar-embedded Mycobacterium abscessus in C57BL/6JNarl mice
    Shiu-Ju Yang et al, 2023, Front. Immunol. CrossRef
  120. The Role of Apelin and Protamine Sulfate in Bile Duct Ligation-Induced Liver Fibrosis in Rats
    Suzan M. M. Moursi et al, 2023, Pharm Chem J CrossRef
  121. Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies
    Lin Jia et al, 2024, Cellular Signalling CrossRef
  122. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors
    Debroop Basu et al, 2023, CTMC CrossRef
  123. Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
    Meghan Mooring et al, 2023, Sci. Transl. Med. CrossRef
  124. Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials
    Xingpeng Di et al, 2024, Clinical & Translational Med CrossRef
  125. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents
    Lin Chen et al, 2024, J. Mater. Chem. B CrossRef
  126. In vivo investigation of the anti-liver fibrosis impact of Balanites aegyptiaca/ chitosan nanoparticles
    Nabila Zein et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  127. The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis
    Karlo Mladenić et al, 2024, Eur J Immunol CrossRef
  128. Flavonoids-based nanomedicine for the treatment of liver fibrosis: A recent progress
    Karthik Shree Harini et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
  129. Dual neovascular targets of vascular endothelial growth factor receptors and platelet‐derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats
    Bin Xiong et al, 2024, Portal Hypertension & Cirrhosis CrossRef
  130. Effects of pulsed electrical stimulation on α-smooth muscle actin and type I collagen expression in human dermal fibroblasts
    Hiroya Urabe et al, 2024 CrossRef
  131. Differential DNA methylation landscape of miRNAs genes in mice liver fibrosis
    Deming Li et al, 2024, Mol Biol Rep CrossRef
  132. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
    Ralf-Peter Czekay et al, 2024, Cells CrossRef
  133. Mimicking chronic alcohol effects through a controlled and sustained ethanol release device
    Wanil Kim et al, 2024, J Biol Eng CrossRef
  134. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao et al, 2024 CrossRef
  135. null
    Maryam Shafaati et al, 2024 CrossRef
  136. Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future
    Wenpeng Huang et al, 2024, VIEW CrossRef